Discover a study that found that the proportion of radical prostatectomies fell from 32.4% in 2010 to just 7.8% by 2020.

ALTHOUGH the incidence of new dementia diagnoses among older Americans has declined in recent years, the overall number of ...

A two-dose primary schedule without booster can provide sufficient protection in high-transmission, resource-limited settings ...

Discover a study that suggests that the infant’s gut microbiota may play a role in both allergy development and tolerance.

Next-generation metagenomic sequencing has uncovered key differences in bronchiectasis pathogens and resistance genes across Europe.

Vagus nerve stimulation improves sleep, mood, and life quality in adult epilepsy patients, with early and sustained effects ...

RESULTS from an international Phase III clinical trial presented at the 2025 ASCO Annual Meeting evaluate a treatment regimen combining encorafenib and cetuximab with mFOLFOX6 chemotherapy in patients ...

Vepdegestrant, an oral PROTAC, nearly doubles progression-free survival in ESR1-mutated, ER-positive advanced breast cancer, ...

Final OS results from INAVO120 show inavolisib plus palbociclib and fulvestrant significantly improves survival, delays ...

Phase 3 trial shows lurbinectedin plus atezolizumab significantly improves progression-free and overall survival in ES-SCLC ...

Children with chronic or life-limiting conditions face high hospitalization rates, ICU use, and in-hospital mortality, ...

This symposium, ‘A case-based approach to navigating treatment switch in late-onset Pompe Disease (LOPD)’, was held at the ...